Sim Y, Park S, Kim S, Lim S, Jung J, Sharma N
Anim Cells Syst (Seoul). 2018; 21(4):278-285.
PMID: 30460079
PMC: 6138324.
DOI: 10.1080/19768354.2017.1345788.
Benso A, Gramaglia E, Olivetti I, Tomelini M, Belcastro S, Calvi E
Endocrine. 2014; 48(3):937-41.
PMID: 25012253
DOI: 10.1007/s12020-014-0343-6.
Santulli G, Iaccarino G
Immun Ageing. 2013; 10(1):10.
PMID: 23497413
PMC: 3763845.
DOI: 10.1186/1742-4933-10-10.
Gojmerac T, Mandic B, Lojkic M, Bilandzic N
Vet Res Commun. 2000; 24(3):179-87.
PMID: 10836276
DOI: 10.1023/a:1006456331361.
Shi C, Taljedal I
Acta Diabetol. 1995; 32(2):116-20.
PMID: 7579532
DOI: 10.1007/BF00569569.
The effect of acebutolol and propranolol on the hypoglycaemic action of glibenclamide.
Zaman R, Kendall M, Biggs P
Br J Clin Pharmacol. 1982; 13(4):507-12.
PMID: 6802160
PMC: 1402050.
DOI: 10.1111/j.1365-2125.1982.tb01412.x.
Effects of short-term thyroxine treatment on pancreatic cytology and responses of blood sugar, serum insulin and serum free fatty acids to epinephrine infusion.
Renauld A, Von Lawzewitsch I, Sverdlik R, Marquez A, Garrido D, Perez R
Acta Diabetol Lat. 1984; 21(3):219-34.
PMID: 6393671
DOI: 10.1007/BF02642895.
Effects of alpha-adrenoceptor antagonists on clonidine-induced inhibition of insulin secretion by isolated pancreatic islets.
Langer J, Panten U, Zielmann S
Br J Pharmacol. 1983; 79(2):415-20.
PMID: 6140041
PMC: 2044869.
DOI: 10.1111/j.1476-5381.1983.tb11014.x.
Can the biochemical responses to a beta 2-adrenoceptor stimulant be used to assess the selectivity of beta-adrenoceptor blockers?.
Rolf Smith S, Kendall M, Worthington D, Holder R
Br J Clin Pharmacol. 1983; 16(5):557-60.
PMID: 6139123
PMC: 1428051.
DOI: 10.1111/j.1365-2125.1983.tb02216.x.
Plasma insulin levels and beta-adrenoceptor antagonists. Relevance of the steric configuration of beta-adrenoceptor antagonists to their effect on glucose tolerance.
Beck A, Conca W, Bacher S, Raberger G
Naunyn Schmiedebergs Arch Pharmacol. 1983; 324(1):46-9.
PMID: 6138714
DOI: 10.1007/BF00647837.
Which beta blocker?.
Breckenridge A
Br Med J (Clin Res Ed). 1983; 286(6371):1085-8.
PMID: 6132652
PMC: 1547455.
DOI: 10.1136/bmj.286.6371.1085.
Plasma insulin levels and beta-adrenoceptor antagonists. The effects of cardioselective and non-cardioselective beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity on basal insulin level and insulin level after glucose....
Conca W, Beck A, Bacher S, Raberger G
Naunyn Schmiedebergs Arch Pharmacol. 1982; 320(1):63-6.
PMID: 6126816
DOI: 10.1007/BF00499074.
[Catecholamines, GH, cortisol, glucagon, insulin, and sex hormones in exercise and beta 1-blockade (author's transl)].
Kindermann W, Schnabel A, Schmitt W, Biro G, Hippchen M
Klin Wochenschr. 1982; 60(10):505-12.
PMID: 6124653
DOI: 10.1007/BF01756096.
Are selective beta-adrenoceptor blocking drugs an advantage?.
Kendall M
J R Coll Physicians Lond. 1981; 15(1):33-40.
PMID: 6109778
PMC: 5377628.
The role of carbohydrate and oral agents in the treatment of diabetes mellitus.
Odell W
Calif Med. 1973; 119(4):37-47.
PMID: 4749311
PMC: 1455263.
Tolbutamide and practolol.
De Divitiis , Gallo B, Isrussi D, JACONO A
Acta Diabetol Lat. 1974; 11(6):495-7.
PMID: 4620123
DOI: 10.1007/BF02624589.
Adrenergic receptors and insulin secretion.
Carandente F
Acta Diabetol Lat. 1973; 10(5):1087-99.
PMID: 4366265
DOI: 10.1007/BF02590704.
Iodoacetamide-induced sensitization of the pancreatic beta-cells to glucose stimulation.
Hellman B, Idahl L, Lernmark A, Sehlin J, Taljedal I
Biochem J. 1973; 132(4):775-89.
PMID: 4198516
PMC: 1177652.
DOI: 10.1042/bj1320775.
Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
Gibson D
Drugs. 1974; 7(1):8-38.
PMID: 4151693
DOI: 10.2165/00003495-197407010-00002.
Effects of beta non-selective and beta 1 selective adrenergic blocking agents on glucagon secretion from isolated perfused rat pancreas.
Gregorio F, Filipponi P, Cristallini S, Carloni C, Moretti I, Ferrandina C
J Endocrinol Invest. 1986; 9(3):209-15.
PMID: 3020114
DOI: 10.1007/BF03348100.
